Health Care
Commentary
Congress: To prevent addiction, empower physicians and patients to choose non-opioids
Every month, it seems, the United States smashes another unenviable record when it comes to drug addiction and overdose statistics. According to the Centers for Disease Control and Prevention (CDC), the latest data show a jaw-dropping 108,000 overdose deaths in 2021. America’s families and communities are reeling — and the federal government ...
Commentary
Improving Access to Paxlovid Long Overdue
The following op-ed has been authored by a non-clinician, it does not constitute medical advice. In an effort to boost access to the antiviral Paxlovid, the Food and Drug Administration (FDA) will now allow pharmacists to prescribe the medicine; the agency announced this last week, on July 6. Previously, patients seeking the ...
Commentary
‘Build Back Better’ would tear down patients’ hope for better medicines
Congressional Democrats are working to revive the multi-trillion-dollar spending package once dubbed “Build Back Better.” They intend to finance this wave of spending in part by siphoning money away from life-saving research on diseases like cancer, heart disease, and Alzheimer’s. That would be the chief consequence of a widely-discussed provision ...
Commentary
New price transparency rule will help patients
This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
Commentary
New price transparency rule will help patients
This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
Blog
An Answer to Our Broken Health Insurance
Even though an increasing share of Americans have health insurance, positive health outcomes and access to health services are actually decreasing, as found in a 2021 study by PRI senior fellow Wayne Winegarden. Why? The insurance model in the United States is deeply broken for many reasons. But it is ...
Commentary
Nothing Curative About Dems Inflation, Higher Taxes and Prices
Congressional Democrats are one step closer to passing their trillion-dollar “Build Back Better” spending package. On July 6 U.S. Senate leaders hashed out a key proposal that would allow Medicare to “negotiate” with pharmaceutical companies over prescription drug prices. The effort is part of Senate Majority Leader Charles Schumer’s, D- N.Y., drive ...
Featured
Wayne Winegarden Plan to Let Medicare Negotiate Drug Prices on Scripps National News
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient costs compared to a plan working its way through Congress to let Medicare negotiate prescription drug prices. ...
Commentary
Centennial State About to Discover Public Option’s Nightmare
Colorado is about to become the first state to implement a public health insurance option through Section 1332, a provision in Obamacare that allows states to waive many of the law’s regulations. The Biden administration approved the program, known as the Colorado Option, on June 23. The new state-sponsored health plan ...
Commentary
Government Drug Price Negotiations Offer A False Promise
With inflation rising and midterm elections just months away, Democrats are desperate for something they can pitch to voters as a reason to keep them in control of Congress. They’re hoping a watered-down version of their Build Back Better Act could do the trick. Sen. Joe Manchin, D-W. Va., who helped shoot the bill ...
Congress: To prevent addiction, empower physicians and patients to choose non-opioids
Every month, it seems, the United States smashes another unenviable record when it comes to drug addiction and overdose statistics. According to the Centers for Disease Control and Prevention (CDC), the latest data show a jaw-dropping 108,000 overdose deaths in 2021. America’s families and communities are reeling — and the federal government ...
Improving Access to Paxlovid Long Overdue
The following op-ed has been authored by a non-clinician, it does not constitute medical advice. In an effort to boost access to the antiviral Paxlovid, the Food and Drug Administration (FDA) will now allow pharmacists to prescribe the medicine; the agency announced this last week, on July 6. Previously, patients seeking the ...
‘Build Back Better’ would tear down patients’ hope for better medicines
Congressional Democrats are working to revive the multi-trillion-dollar spending package once dubbed “Build Back Better.” They intend to finance this wave of spending in part by siphoning money away from life-saving research on diseases like cancer, heart disease, and Alzheimer’s. That would be the chief consequence of a widely-discussed provision ...
New price transparency rule will help patients
This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
New price transparency rule will help patients
This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
An Answer to Our Broken Health Insurance
Even though an increasing share of Americans have health insurance, positive health outcomes and access to health services are actually decreasing, as found in a 2021 study by PRI senior fellow Wayne Winegarden. Why? The insurance model in the United States is deeply broken for many reasons. But it is ...
Nothing Curative About Dems Inflation, Higher Taxes and Prices
Congressional Democrats are one step closer to passing their trillion-dollar “Build Back Better” spending package. On July 6 U.S. Senate leaders hashed out a key proposal that would allow Medicare to “negotiate” with pharmaceutical companies over prescription drug prices. The effort is part of Senate Majority Leader Charles Schumer’s, D- N.Y., drive ...
Wayne Winegarden Plan to Let Medicare Negotiate Drug Prices on Scripps National News
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient costs compared to a plan working its way through Congress to let Medicare negotiate prescription drug prices. ...
Centennial State About to Discover Public Option’s Nightmare
Colorado is about to become the first state to implement a public health insurance option through Section 1332, a provision in Obamacare that allows states to waive many of the law’s regulations. The Biden administration approved the program, known as the Colorado Option, on June 23. The new state-sponsored health plan ...
Government Drug Price Negotiations Offer A False Promise
With inflation rising and midterm elections just months away, Democrats are desperate for something they can pitch to voters as a reason to keep them in control of Congress. They’re hoping a watered-down version of their Build Back Better Act could do the trick. Sen. Joe Manchin, D-W. Va., who helped shoot the bill ...
